WCA
LLY icon

Waratah Capital Advisors’s Eli Lilly LLY Stock Holding History

Waratah Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,904
Closed -$1.02M – 181
2023
Q3 		$1.02M Buy
+1,904
New +$981K 0.01% 138

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Waratah Capital Advisors's LLY Position: Q4 2023 in Review

Waratah Capital Advisors sold out of Eli Lilly (LLY) in Q4 2023, closing a stake of 1,904 shares — an estimated $1.02M sold.

Waratah Capital Advisors first reported a position in LLY in Q3 2023 and held it in 1 quarter. The position peaked at $1.02M in Q3 2023. 3,273 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

  • Waratah Capital Advisors reported no remaining Eli Lilly position as of Q4 2023 after selling out during the quarter.
  • Waratah Capital Advisors sold 1,904 Eli Lilly shares in Q4 2023, an estimated $1.02M.
  • Waratah Capital Advisors first reported a position in Eli Lilly in Q3 2023 and held it in 1 quarter.
  • Waratah Capital Advisors's Eli Lilly position peaked at $1.02M in Q3 2023.
  • 3,273 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Waratah Capital Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.